ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

18 links0 made here, not in the record29 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06840886A Study of PHST001 inAdvanced Solid TumorsPheast TherapeuticsPhase 1 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 5 · ClinicalTrials.gov record · Version of 2026-10-05Version of 2026-10-05CONDITIONSOvarian NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionEndometrial NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termCholangiocarcinomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termCentral Nervous System Neop…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termBreast NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termFallopian Tube NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termCarcinosarcomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termDRUGSINT012592Entry “PHST001”, read by our name rule›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPaclitaxelIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundTopotecanIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundDoxorubicinIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundINT009683Entry “FOLFIRI”, read by our name rule›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundINT013508Entry “FOLFIRI”, read by our name rule›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundFolfox protocolEntry “FOLFOX”, read by our name rule›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundGemcitabineIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundMirvetuximab soravtansineIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTrastuzumab deruxtecanIntervention entry›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerTrastuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · Not givenNot given

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

INT012592

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “PHST001”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Oct 5The record itselfClinicalTrials.gov recordVersion of 2026-10-05Record change
Nov 2INT012592Claude Opus 5.5TestedCurrent
Nov 2PaclitaxelClaude Opus 5.5BackgroundCurrent
Nov 2TopotecanClaude Opus 5.5BackgroundCurrent
Nov 2DoxorubicinClaude Opus 5.5BackgroundCurrent
Nov 2INT009683Claude Opus 5.5BackgroundCurrent
Nov 2INT013508Claude Opus 5.5BackgroundCurrent
Nov 2Folfox protocolClaude Opus 5.5BackgroundCurrent
Nov 2GemcitabineClaude Opus 5.5BackgroundCurrent
Nov 2Mirvetuximab soravtansineClaude Opus 5.5TestedCurrent
Nov 2Trastuzumab deruxtecanClaude Opus 5.5Background · partnerCurrent
Nov 2TrastuzumabClaude Opus 5.5Not givenCurrent
Nov 14Ovarian NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Endometrial NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14CholangiocarcinomaRule based · condition-kind ruleFinest filed termCurrent
Nov 14Central Nervous System NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Breast NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Fallopian Tube NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14CarcinosarcomaRule based · condition-kind ruleFinest filed termCurrent
Nov 18INT012592Rule based · role ruleTestedAgrees
Nov 18PaclitaxelRule based · role ruleBackgroundAgrees
Nov 18TopotecanRule based · role ruleBackgroundAgrees
Nov 18DoxorubicinRule based · role ruleBackgroundAgrees
Nov 18INT009683Rule based · role ruleBackgroundAgrees
Nov 18INT013508Rule based · role ruleBackgroundAgrees
Nov 18Folfox protocolRule based · role ruleBackgroundAgrees
Nov 18GemcitabineRule based · role ruleBackgroundAgrees
Nov 18Mirvetuximab soravtansineRule based · role ruleTestedAgrees
Nov 18Trastuzumab deruxtecanRule based · role ruleBackgroundAgrees
As of nowOvarian NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.